Nereus Message Board - Msg: 22763775

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nereus

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (7)	8/29/2006 9:16:43 PM
From: Mike McFarland	of 19

NPI-2358 demonstrated it is a potent and selective tumor vascular disrupting agent (VDA). nereuspharm.com Nereus will be at the 4th Annual "Angiogenesis and Vascular Targeting Agents in Drug Discovery & Development" in Boston, MA September 19 to 20, 2006

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next